{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:34:20Z","timestamp":1791232460308,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006559","name":"University of Tsukuba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clim.2026.110702","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:45:57Z","timestamp":1774658757000},"page":"110702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"285","author":[{"given":"Anouar","family":"Oudhini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Elghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Zanina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Changuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Sakly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.clim.2026.110702_bb0005","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.3390\/ijms25158155","article-title":"Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment strategies","volume":"25","author":"Chung","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110702_bb0010","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1186\/s12889-024-19264-5","article-title":"Post-COVID syndrome prevalence: a systematic review and meta-analysis","volume":"24","author":"Sk Abd Razak","year":"2024","journal-title":"BMC Public Health"},{"issue":"14","key":"10.1016\/j.clim.2026.110702_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.64.14.37","article-title":"Neuro-ophthalmic adverse events of COVID-19 infection and vaccines: a nationwide cohort study","volume":"64","author":"Han","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10072-024-07870-5","article-title":"Impact of COVID-19 disease and COVID-19 vaccinations on hospital admissions for neurological diseases in the Lombardia over-12 population. Data from a self-controlled case series analysis","volume":"46","author":"Salmaggi","year":"2025","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0025","doi-asserted-by":"crossref","first-page":"e0315499","DOI":"10.1371\/journal.pone.0315499","article-title":"Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination","volume":"19","author":"Guerrerio","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clim.2026.110702_bb0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2025.02.005","article-title":"Autoimmunity in long COVID","volume":"155","author":"Talwar","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110702_bb0035","first-page":"102216","article-title":"From infection to autoimmunity: can COVID-19 spark new auto-immune conditions?","volume":"55","author":"Elghali","year":"2025","journal-title":"Respir. Med. Case Rep."},{"issue":"2","key":"10.1016\/j.clim.2026.110702_bb0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11845-025-03886-8","article-title":"Prevalence of anti-nuclear antibodies in COVID-19 patients: a remarkable 2.5-fold rise compared to healthy controls","volume":"194","author":"Di\u015fli","year":"2025","journal-title":"Ir. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0045","doi-asserted-by":"crossref","first-page":"e2507","DOI":"10.1002\/rmv.2507","article-title":"Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials","volume":"34","author":"Beladiya","year":"2024","journal-title":"Rev. Med. Virol."},{"issue":"10","key":"10.1016\/j.clim.2026.110702_bb0050","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/biom14101320","article-title":"The ambivalence of post COVID-19 vaccination responses in humans","volume":"14","author":"Gopalaswamy","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.clim.2026.110702_bb0055","doi-asserted-by":"crossref","DOI":"10.7774\/cevr.2025.14.e34","article-title":"Autoimmune manifestations recorded after SARS-CoV-2 vaccination","volume":"14","author":"Elghali","year":"2025","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0060","doi-asserted-by":"crossref","first-page":"103508","DOI":"10.1016\/j.autrev.2023.103508","article-title":"Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines","volume":"23","author":"Hromi\u0107-Jahjefendi\u0107","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2026.110702_bb0065","doi-asserted-by":"crossref","first-page":"1429848","DOI":"10.3389\/fendo.2024.1429848","article-title":"Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00415-024-12186-7","article-title":"Guillain\u2013Barr\u00e9 syndrome and COVID-19 vaccination: a systematic review and meta-analysis","volume":"271","author":"Censi","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2026.110702_bb0075","doi-asserted-by":"crossref","first-page":"105918","DOI":"10.1016\/j.ijsu.2021.105918","article-title":"PRISMA 2020 statement: what\u2019s new and the importance of reporting guidelines","volume":"88","author":"Sohrabi","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.clim.2026.110702_bb0080","doi-asserted-by":"crossref","first-page":"108602","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00277-020-04256-3","article-title":"Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection","volume":"100","author":"Algassim","year":"2021","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3803\/EnM.2021.983","article-title":"Insights from a prospective follow-up of thyroid function and autoimmunity among COVID-19 survivors","volume":"36","author":"Lui","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-022-06180-3","article-title":"SARS CoV- 2 vaccination induces antibodies against cardiolipin","volume":"15","author":"Krashias","year":"2022","journal-title":"BMC Res. Notes"},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0100","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.2022.14092","article-title":"SARS-CoV-2 infections and presymptomatic type 1 diabetes autoimmunity in children and adolescents from Colorado, USA, and Bavaria, Germany","volume":"328","author":"Rewers","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clim.2026.110702_bb0105","doi-asserted-by":"crossref","first-page":"e2233014","DOI":"10.1001\/jamanetworkopen.2022.33014","article-title":"Association of SARS-CoV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021","volume":"5","author":"Kendall","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.clim.2026.110702_bb0110","first-page":"459","article-title":"The evaluation of pancreas \u03b2-cell autoantibodies in non-diabetic COVID-19 patients","volume":"66","author":"Kayhan","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/ijms24010211","article-title":"Longitudinal analysis of antiphospholipid antibody dynamics after infection with SARS-CoV-2 or vaccination with BNT162b2","volume":"24","author":"Ogri\u010d","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110702_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221127276","article-title":"Association of lupus anticoagulant status with disease course in SARS-CoV-2 (COVID-19) infection","volume":"28","author":"Woo","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.clim.2026.110702_bb0125","doi-asserted-by":"crossref","first-page":"953043","DOI":"10.3389\/fimmu.2022.953043","article-title":"Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: a single-center prospective study on 151 pregnancies","volume":"13","author":"Gozzoli","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110702_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.clim.2026.110702_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMc2216477","article-title":"SARS-CoV-2 \u2014 No increased islet autoimmunity or type 1 diabetes in teens","volume":"389","author":"Krischer","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaad.2024.10.063","article-title":"COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: a large-scale population-based cohort study of 112 million individuals","volume":"92","author":"Curman","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.clim.2026.110702_bb0145","doi-asserted-by":"crossref","first-page":"e2336120","DOI":"10.1001\/jamanetworkopen.2023.36120","article-title":"Autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"6","author":"Lim","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.clim.2026.110702_bb0150","doi-asserted-by":"crossref","first-page":"102154","DOI":"10.1016\/j.eclinm.2023.102154","article-title":"Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study","volume":"63","author":"Peng","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.clim.2026.110702_bb0155","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s10067-023-06670-0","article-title":"Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study","volume":"42","author":"Tesch","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2026.110702_bb0160","doi-asserted-by":"crossref","first-page":"111599","DOI":"10.1016\/j.intimp.2024.111599","article-title":"Autoantibody profiles assessment in individuals with persistent olfactory impairment following SARS-CoV-2 infection","volume":"129","author":"Fiorelli","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2026.110702_bb0165","doi-asserted-by":"crossref","first-page":"1337406","DOI":"10.3389\/fimmu.2024.1337406","article-title":"New-onset autoimmune disease after COVID-19","volume":"15","author":"Hileman","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2026.110702_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/RHU.0000000000002054","article-title":"Persistent risk of developing autoimmune diseases associated With COVID-19: an observational study using an electronic medical record database in Japan","volume":"30","author":"Inokuchi","year":"2024","journal-title":"J. Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2026.110702_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1684\/ejd.2024.4646","article-title":"Risk of vitiligo in patients with SARS-CoV-2 vaccination or infection: a nationwide cohort study","volume":"34","author":"Kim","year":"2024","journal-title":"Eur. J. Dermatol."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.7326\/M23-1831","article-title":"Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19\u00a0: A Binational Cohort Study","volume":"177","author":"Kim","year":"2024","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0185","doi-asserted-by":"crossref","first-page":"116284","DOI":"10.1016\/j.diagmicrobio.2024.116284","article-title":"Increased rheumatoid factor production in patients with severe COVID-19","volume":"109","author":"Elghali","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.clim.2026.110702_bb0190","doi-asserted-by":"crossref","first-page":"103299","DOI":"10.1016\/j.jaut.2024.103299","article-title":"Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies","volume":"148","author":"Oakes","year":"2024","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.clim.2026.110702_bb0195","doi-asserted-by":"crossref","first-page":"e1276","DOI":"10.1002\/iid3.1276","article-title":"The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19","volume":"12","author":"Roghani","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0200","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamadermatol.2024.4233","article-title":"Long-term risk of autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"160","author":"Heo","year":"2024","journal-title":"JAMA Dermatol."},{"issue":"8","key":"10.1016\/j.clim.2026.110702_bb0205","doi-asserted-by":"crossref","first-page":"e2430983","DOI":"10.1001\/jamanetworkopen.2024.30983","article-title":"Autoimmune sequelae after delta or omicron variant SARS-CoV-2 infection in a highly vaccinated cohort","volume":"7","author":"Wee","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.clim.2026.110702_bb0210","doi-asserted-by":"crossref","first-page":"102830","DOI":"10.1016\/j.jaut.2022.102830","article-title":"Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong","volume":"130","author":"Li","year":"2022","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0215","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3390\/v14122655","article-title":"The risk of autoimmunity development following mRNA COVID-19 vaccination","volume":"14","author":"\u015awierkot","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.clim.2026.110702_bb0220","doi-asserted-by":"crossref","first-page":"930074","DOI":"10.3389\/fimmu.2022.930074","article-title":"Anti-phospholipid antibodies and coronavirus disease 2019: vaccination does not trigger early autoantibody production in healthcare workers","volume":"13","author":"Borghi","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2026.110702_bb0225","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12026-022-09309-5","article-title":"The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels","volume":"70","author":"Noureldine","year":"2022","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0230","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41467-022-32264-6","article-title":"Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland","volume":"13","author":"Simpson","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.clim.2026.110702_bb0235","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2024.01.099","article-title":"Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - a self-controlled case series analysis","volume":"42","author":"Morgan","year":"2024","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0240","doi-asserted-by":"crossref","first-page":"2200195","DOI":"10.2807\/1560-7917.ES.2023.28.3.2200195","article-title":"Adverse events following first and second dose COVID-19 vaccination in England, october 2020 to september 2021: a national vaccine surveillance platform self-controlled case series study","volume":"28","author":"Tsang","year":"2023","journal-title":"Euro Surveill."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0245","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1038\/s41598-023-30940-1","article-title":"Real-world data on the incidence and risk of Guillain-Barr\u00e9 syndrome following SARS-CoV-2 vaccination: a prospective surveillance study","volume":"13","author":"Ha","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clim.2026.110702_bb0250","doi-asserted-by":"crossref","first-page":"e2253845","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0255","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1111\/ene.16025","article-title":"Association between COVID-19 vaccination and myasthenia gravis: a population-based, nested case-control study","volume":"30","author":"Arbel","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.clim.2026.110702_bb0260","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaci.2024.01.025","article-title":"Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea","volume":"153","author":"Kim","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2026.110702_bb0265","doi-asserted-by":"crossref","first-page":"1058007","DOI":"10.3389\/fendo.2023.1058007","article-title":"Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: a twelve-month follow-up study","volume":"14","author":"Morita","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.clim.2026.110702_bb0270","doi-asserted-by":"crossref","first-page":"904796","DOI":"10.3389\/fneur.2022.904796","article-title":"Frequency of neurological diseases after COVID-19, influenza a\/B and bacterial pneumonia","volume":"13","author":"Zarifkar","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2026.110702_bb0275","doi-asserted-by":"crossref","first-page":"101932","DOI":"10.1016\/j.eclinm.2023.101932","article-title":"Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study","volume":"58","author":"Voss","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clim.2026.110702_bb0280","series-title":"Immunobiology: The Immune System in Health and Disease","article-title":"Principles of innate and adaptive immunity","author":"Charles A Janeway","year":"2001"},{"issue":"7","key":"10.1016\/j.clim.2026.110702_bb0285","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11427-021-2187-3","article-title":"Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections","volume":"66","author":"Chi","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-025-09124-4","article-title":"Association between COVID-19 and new-onset autoimmune diseases: updated systematic review and meta-analysis of 97 million individuals","volume":"68","author":"Tzang","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2026.110702_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cytogfr.2023.11.005","article-title":"COVID-19: from emerging variants to vaccination","volume":"76","author":"Senevirathne","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.clim.2026.110702_bb0300","doi-asserted-by":"crossref","first-page":"e26577","DOI":"10.1016\/j.heliyon.2024.e26577","article-title":"SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors","volume":"10","author":"Behboudi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.clim.2026.110702_bb0305","doi-asserted-by":"crossref","first-page":"1498445","DOI":"10.3389\/fpubh.2025.1498445","article-title":"COVID-19 clinical presentation, management, and epidemiology: A concise compendium","volume":"13","author":"Maison","year":"2025","journal-title":"Front. Public Health"},{"issue":"175","key":"10.1016\/j.clim.2026.110702_bb0310","doi-asserted-by":"crossref","first-page":"240222","DOI":"10.1183\/16000617.0222-2024","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of european studies published up to 22 january 2024","volume":"34","author":"Zhou","year":"2025","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0315","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/vaccines12030334","article-title":"SARS-CoV-2 vaccine safety and autoimmune response","volume":"12","author":"Tyan","year":"2024","journal-title":"Vaccines"},{"issue":"4\u20136","key":"10.1016\/j.clim.2026.110702_bb0320","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00281-023-00996-2","article-title":"The role of vaccines in the COVID-19 pandemic: what have we learned?","volume":"45","author":"Krammer","year":"2024","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.clim.2026.110702_bb0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-023-03049-5","article-title":"Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care","volume":"21","author":"Syed","year":"2023","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.clim.2026.110702_bb0330","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2337\/dc22-2351","article-title":"Risk of type 1 diabetes in children is not increased after SARS-CoV-2 infection: a nationwide prospective study in Denmark","volume":"46","author":"Noorzae","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.clim.2026.110702_bb0335","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc14-1140","article-title":"Type 1 diabetes sourcebook authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association","volume":"37","author":"Chiang","year":"2014","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0340","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1007\/s00296-024-05733-y","article-title":"Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a nation-wide cohort study","volume":"44","author":"Bournia","year":"2024","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2026.110702_bb0345","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin. Immunol. Orlando Fla."},{"issue":"4","key":"10.1016\/j.clim.2026.110702_bb0350","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jocd.15550","article-title":"Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: clinical pearls for dermatologists","volume":"22","author":"Aryanian","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.clim.2026.110702_bb0355","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jdin.2025.09.007","article-title":"Viral infections as triggers in autoimmune blistering diseases: a systematic review of associations and mechanisms","volume":"24","author":"Tseng","year":"2025","journal-title":"JAAD Int."},{"issue":"3","key":"10.1016\/j.clim.2026.110702_bb0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2023.09.019","article-title":"Retinal artery and vein occlusion risks after coronavirus disease 2019 or coronavirus disease 2019 vaccination","volume":"131","author":"Park","year":"2024","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.clim.2026.110702_bb0365","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2352-4642(25)00247-0","article-title":"Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records","volume":"9","author":"Sampri","year":"2025","journal-title":"Lancet Child Adol. Health"},{"issue":"5","key":"10.1016\/j.clim.2026.110702_bb0370","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/cap.2024.0129","article-title":"Pediatric neuropsychiatric syndromes: updates on COVID-19 infection and vaccination","volume":"35","author":"O\u2019Dor","year":"2025","journal-title":"J. Child Adolesc. Psychopharmacol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:38:15Z","timestamp":1779190695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"alternative-id":["S1521661626000409"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110702","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110702"}}